张江基地定位在开发与应用,为重点实验室研究成果解决国家战略需求做贡献。你知道支撑我国抗体和疫苗产业的四大关键核心技术吗?1月22日上午,记者来到在张江基地建设了一条年产百万升的中试生产线的华东理工大学实验1楼18层的生物反应器工程国家重点实验室(以下简称“实验室”),专访深耕于抗体与疫苗领域动物细胞大规模培养20余年的谭文松教授,探寻其团队如何在崭新的2017年扛起我国抗体和疫苗产业的后盾,其生产制造技术如何在张江国家自主创新 Zhangjiang base is located in the development and application of research results for key laboratories to contribute to the country’s strategic needs. Do you know the four key core technologies that support China’s antibody and vaccine industry? On the morning of January 22, reporters came to the 18th floor of the 1st floor of East China University of Science and Technology in Zhangjiang to build a pilot plant with an annual output of 1 million liters The State Key Laboratory of Bioreactor Engineering (hereinafter referred to as “Laboratory”) interviewed Professor Tan Wensong, who intensively cultivated animal cells in the field of antibodies and vaccines for more than 20 years and explored how his team could lift up our antibody in the new 2017 And the backing of the vaccine industry, how its manufacturing technology in Zhangjiang country independent innovation